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Introduction
------------

Despite the nearing deadline for attaining the World Health Organization\'s Millennium Development Goals that include improving maternal health worldwide by 2015, the reality remains that over one-half million expectant or new mothers die suddenly and unpredictably \[[@B1],[@B2]\]. Although 90% of these deaths occur in developing countries, intensivists in developed nations are also confronted by unexpected critical illnesses in pregnancy, often in otherwise previously healthy women. These illnesses, most commonly preeclampsia and obstetric hemorrhage, can result in significant morbidity and mortality in both mother and newborn \[[@B3],[@B4]\]. Further complicating the situation, intensivists are often unfamiliar with maternal-fetal physiology both in health and in critical illness \[[@B3]\], and perhaps do not consider the possible impact of intra-abdominal pressure (IAP) and intra-abdominal hypertension (IAH) on such conditions.

Since the inception of the World Society of the Abdominal Compartment Syndrome (WSACS) in 2004, many advances in the recognition, the treatment, and especially the prevention of the abdominal compartment syndrome (ACS) have occurred \[[@B5],[@B6]\]. When clinicians are vigilant and make efforts to detect and treat raised IAP, it appears that deadly ACS may often be avoided, especially with the adoption of newer resuscitation strategies \[[@B7],[@B8]\]. Such advances have led some to propose that the future efforts of the WSACS should be focused on the more prevalent but less understood precursor condition of IAH, rather than the overtly catastrophic ACS. This rapid evolution in practice in the fields of critical care and trauma has been associated with a relative explosion in the published world literature, focusing on critical care, trauma, medical, and surgical populations \[[@B9]\].

However, despite seminal work early in the twentieth century by an obstetrician, Paramore \[[@B10]\], there has been almost no recognition or appreciation of the potential presence, influence, and management of IAH in pregnancy and the peripartum state, other than dramatic case reports in which ACS was only recognized in a parturient *in extremis*\[[@B11]-[@B13]\]. As pregnancy is a natural but dramatic physiologic state that can occur at some point in the lifetime of approximately half of the world\'s population, further understanding and research is urgently needed. Critical illness in pregnancy, unfortunately, is not uncommon, given that the population-based incidence of severe obstetric morbidity has been reported to be as high as 1.2% in the UK \[[@B14]\]. In the USA, the American College of Obstetricians and Gynecologists published an overall estimate that critical care services were required in 1% to 3% of pregnant women \[[@B4]\], in whom diagnoses of maternal hypertension and hemorrhage were the most cited causes of critical care admission \[[@B4]\]. The relevance of greater understanding and education in both the behavior and measurement of the IAP in pregnancy is illustrated by the following case, aspects of which, primarily relating to the infectious etiology of the case, have previously been described \[[@B15]\].

Illustrative case
-----------------

A 16-year-old female, estimated to be at 32 weeks gestation, was transferred to a tertiary intensive care unit (ICU) from a peripheral hospital. She required intubation and ventilation following a 2-week prodrome of progressive cough. Her ICU admission revealed severe hypoxemia with a PaO~2~/FiO~2~ratio of 53, despite receiving 100% fractional inspired oxygen (FiO~2~). Her initial lactate was 2.1 mmol/l, hemoglobin was 10.5 g/dl, and creatinine was 58 μmol/l with a urine output of greater than 30 ml/h. Her physiologic data can be found in Table [1](#T1){ref-type="table"}. A fetal ultrasound revealed a poor biophysical profile score of 2/8; however, under conditions of maternal sedation and pharmacologic paralysis, this was non-diagnostic in determining fetal well-being. There was a normal amniotic fluid volume and a fetal heart rate of 156 beats/min. As a result, the obstetrical consult regarding the issue of fetal delivery was noncommittal, and the patient was inadvertently lost to follow up by obstetrics during her subsequent ICU course.

###### 

Physiologic variables of reported case

  Admission                     Prior to laparotomy
  ----------------------------- ---------------------------------
  MAWP = 44.5 mmHg              MAWP = 50 mmHg
  SpO~2~= 83%                   SpO~2~= 80%
  FiO~2~= 100%                  FiO~2~= 100%
  7.32/52/53/26 BE = 0 mmol/l   7.23/83/55/33 BE = 4 mmol/l
  UO = 27 to 185 ml/h           UO = 0 ml/h
  CVP = 14 mmHg                 CVP = 24 mmHg
  No inotrope support           Norepinephrine = 0.06 μg/kg/min

MAWP, mean airway pressure; SpO~2~, pulse oximetry; FiO~2~, fractional inspired oxygen; BE, base excess; UO, urine output; CVP, central venous pressure.

The patient was ventilated using high-frequency oscillatory ventilation in combination with nitric oxide (NO), but the oxygenation did not improve significantly. Within 15 h of admission, bilateral chest tubes were required for presumed barotrauma-related pneumothoraces. She became anuric in association with a rising creatinine of 122 μmol/l. Nine hours later, she further decompensated, requiring an increase of the mean airway pressure (MAWP) to 50 cmH~2~O. The central venous pressure (CVP) increased to 27 mmHg, and severe subcutaneous emphysema developed \'from head to toe\'. Transthoracic echocardiography revealed a hyperdynamic, underfilled heart. She continued to deteriorate, prompting a consult to cardiac surgery for extracorporeal life support (ECLS) as a last resort to her spiraling physiologic decline.

Obstetrics was re-consulted and noted that sonographic windows during a repeat fetal ultrasound were completely absent. After much debate, it was decided that cannulation for ECLS would precede a caesarean section (CS). In the operating room, the ECLS cannulation procedure proved difficult and prolonged, resulting in iatrogenic injuries to both the groin and subclavian vessels, and transfusion of six units of red blood cells. Finally, after cannulation, the ECLS circulatory flows were inadequate at 1 to 1.5 l/min.

Thereafter, the CS was performed by a midline laparotomy. Upon incising the peritoneum, an unexpected gush of air was released. There was an immediate improvement in mechanical ventilation; pulse oximetry (SpO~2~) increased above 90% for the first time since her admission. The ECLS flows only improved partially. The fetus was successfully delivered within 20 min. Upon evacuation of the uterus, there was a distinct improvement in the patient\'s ventilation and oxygenation. The ECLS flows immediately improved to normal levels (4 to 4.5 l/min); SpO~2~was 100%; and the NO and jet ventilator were quickly weaned. There was a spontaneous diuresis of clear urine intraoperatively. The neonate was intubated after delivery, immediately taken to the neonatal intensive care unit, and eventually discharged on day 27 but had multiple hospital admissions thereafter.

Postoperatively, the inciting etiology of fulminant adult respiratory distress syndrome (ARDS) was determined to be caused by a severe influenza A infection, prompting publication of a plea for routine vaccination of all eligible patients with the influenza vaccine, although no mention of the potential role of ACS was made \[[@B15]\]. The mother herself underwent 2 weeks of ECLS support, repeated upper gastrointestinal bleeding due to systemic heparinization, the administration of 98 units of blood products, and several ECLS circuit thromboses. Although no preoperative IAP measurements had been obtained, postoperative IAP was 14 mmHg. She was discharged home 6 weeks later.

The evidence to support the conclusion that ACS significantly contributed to her spiraling decline included the high MAWP of 50 mmHg, a well-described inciting factor for tension pneumoperitoneum \[[@B16]-[@B22]\]. The progressive worsening of her ventilatory parameters, anuria, and elevated CVP in the face of a normal cardiac function, almost completely relieved by the release of a large \'gush\' of air during laparotomy, strongly supported the contention that her ARDS was complicated by an unrecognized but classic presentation of fulminant ACS \[[@B23],[@B24]\].

The physiology of normal pregnancy
----------------------------------

As IAH/ACS impacts almost all of the body\'s organ systems, it is important for intensivists to understand the normal alterations in these systems that occur with pregnancy. The pregnant state involves a complex and remarkable interplay of both adaptive and supportive physiology, allowing a fetus to grow and thrive for a finite duration *in utero*until such time it is ready for a physically independent life. The maternal physiologic changes that occur in pregnancy are multisystemic and far-reaching, not the least of which is the adaptation to accommodate the gravid uterus. On average, the uterus contributes 1 kg to the overall weight gain in pregnancy, while the amniotic fluid, fetus, and placenta comprise approximately 5 kg in additional weight \[[@B25]\].

To accommodate this growth, the thoracic cage increases in both anteroposterior and transverse diameters \[[@B25]\]. The hormone relaxin, released by the corpus luteum and placenta, results in targeted softening of the ligamentous structures to also compensate for uterine growth \[[@B26]\]. The diaphragm becomes elevated as a result of being pushed cephalad by the uterus, impeding the functional residual capacity by at least 20% \[[@B25]\]. Tidal volume increases and is associated with a 45% increase in minute and alveolar ventilation \[[@B25]\]. Overall maternal metabolic rate, oxygen consumption (VO~2~), gas exchange, and acid/base balance are all affected by several factors including the growth of the feto-placental unit, progesterone levels, and carbon dioxide production. On average, maternal VO~2~increases by 15% to 20% \[[@B27]\], although in one study, VO~2~increased with advancing gestation by 28% \[[@B28]\]. With increased ventilation, the resulting respiratory alkalosis is renally compensated through a reduction of serum bicarbonate to 20 mEq/L and total buffer base capacity to 5 mEq/L \[[@B25]\]. Thus, when critically ill, the parturient is more vulnerable to hypoxemia and acidemia, with overall less physiologic reserve, than when nonpregnant \[[@B27]\].

In addition, there is a 50% increase in plasma volume resulting in dilutional anemia and overall increase in circulating blood volume of 40% \[[@B25],[@B27]\]. Cardiac output increases by 30% to 50%; blood flow to the gravid uterus increases tenfold \[[@B27]\]. After 20 weeks of gestation, the uterus size can cause a mechanical aorto-caval obstruction while fully supine and can result in the \'supine-hypotensive syndrome\': significant loss of venous return for which the cardiovascular system cannot compensate \[[@B25]\]. However, the majority of women develop collateral circulation through interosseus vertebral, paravertebral, epidural, and ovarian venous systems \[[@B25]\]. It has been suggested that those who suffer from supine-hypotensive syndrome likely do not develop adequate collateral circulation \[[@B29]\]. While only approximately 8% of women at term experience this life-threatening situation, significant compression of the inferior vena cava (IVC) while supine does occur in the majority of women \[[@B25],[@B29]\]. Whether elevated IAP can exacerbate aorto-caval compression and has a relationship with this syndrome is unknown. Thus, due to the myriad of hormonal, mechano-physiologic changes, the majority of parturients are well compensated for the exponential growth of their fetus in a relatively short duration of time.

IAP and pregnancy
-----------------

Knowledge of normal versus pathologic IAPs for any population in the ICU would seem intuitive for patient care \[[@B30]\]. To date, however, there is very little actual data regarding physiologic and pathophysiologic IAP in pregnancy. Current consensus guidelines group pregnancy and morbid obesity together as chronically compensated states of IAH \[[@B31]\]. However, the growth of each gestational age during pregnancy as well as the unique anatomic impact as the uterus grows from the pelvis into the abdominal cavity has never been taken into account. Unlike pregnancy, chronic obesity is the deposition of fat diffusely throughout the abdominal cavity. The implication of this anatomical difference could be considered semantic by some, but could be considered significant, given that the standard of measurement of IAP uses the intra-vesicular pressure as a surrogate; the location of which rests in the pelvis.

The state of the science in this regard is well symbolized by the fact that until very recently, the best evidence concerning IAP in pregnancy was obtained through rectal manometry on primarily primigravid inmates of an institution for \'fallen women\' and published in 1913 \[[@B10]\]. More recently, however, Al-Khan and colleagues \[[@B32]\] published more contemporary IAP intravesical measurements in 100 healthy term parturients obtained under spinal anesthesia just prior to commencement of elective CS. These and all IAP data to date can be found in Table [2](#T2){ref-type="table"}. They found the median IAP in a leftward tilted position to be 22 ± 2.9 mmHg (range 15 to 29 mmHg), pressures actually in the threshold range for ACS if organ failure were also present \[[@B31]\]. Postoperatively, after neonatal delivery, the IAP dropped significantly to a median IAP of 16 mmHg (range 11 to 24 mmHg) \[[@B32]\]. Besides questions regarding the fluid volume of bladder priming for IAP measurement and unknown spinal anesthesia dermatome distribution, the greatest question from this study is the unspecified degree of left lateral tilt during the IAP measurements, making it difficult to reconcile if these measurements reflected the actual abdominal IAP or the weight of the gravid uterus on the bladder itself.

###### 

Physiologic IAP in pregnancy

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                      Year   *n*   Gestation          Positions during IAP measurement          IAP~mean~\     Comments
                                                                                                        (mmHg)         
  --------------------------- ------ ----- ------------------ ----------------------------------------- -------------- ----------------------------------------------------------------------------------------------------
  Paramore \[[@B10]\]         1913   24    6 months to term   Supine; left side; knee chest; standing   Range\         Rectal manometer; ambulatory subjects
                                                                                                        15 to 44       

  Cuppett et al. \[[@B62]\]   2008   40    Term               Supine;\                                  Not reported   Elective CS under spinal anesthesia
                                                              Left Lateral                                             

  Sugerman \[[@B49]\]         2011   5     39 weeks           Supine;\                                  25 ± 3;\       Unclear methods; likely ambulatory patients
                                                              Left Lateral decubitus                    23 ± 3         

  Al-Khan et al. \[[@B32]\]   2011   100   36 to 41 weeks     Leftward tilt                             22 ± 2.9       Elective CS; Unspecified leftward tilt; 50 ml saline instilled in bladder; unclear reference point

  Chun et al. \[[@B33]\]      2012   20    38 to 40 weeks     Supine;\                                  10 ± 4.7\      Elective CS under spinal anesthesia; leftward tilt 10^0^
                                                              Leftward tilt                             8.9 ± 4.9      
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IAP~mean~, mean intra-abdominal pressure; *n*, number; CS, caesarean section.

We similarly measured the IAP in 20 term parturients under spinal anesthesia \[[@B33]\]. The IAP measurement was significantly higher in the fully supine position (0°) compared to when the operating table was leftward tilted to 10° with the reference point held constant by placing the bladder pressure transducer in a line adjacent to the patient on an intravenous pole. We thus hypothesized that the weight of the gravid uterus might have directly impacted on the bladder, thereby falsely elevating the IAP measurement when fully supine.

Thus, the above studies highlight currently unresolved issues regarding the necessary trade-offs between the use of a standardized and reproducible reference position to obtain meaningful IAP data, and the reality of patient safety. This is akin to the concern regarding the positioning of ventilated patients fully supine to measure IAP, while increasing aspiration risks \[[@B30],[@B34],[@B35]\]. Left lateral tilt has become the standard of care in CS, particularly after spinal anesthesia, as a means to both facilitate CS and alleviate potential aorto-caval compression while supine \[[@B36]\]. There is debate as to the degree of tilt required to minimize compression of the IVC by the uterus \[[@B36],[@B37]\]; a tilt of 15° is generally recommended \[[@B36]\]. What remains unknown is the effect of the gravid uterus on measured bladder pressure in varying relative positions to each other. Questions arise as to the validity of the IAP measurement as recommended by the WSACS guidelines in a pregnant patient from early second trimester onwards. Current recommended guidelines describe IAP measurement in the fully supine position at end-expiration \[[@B38],[@B39]\]. Such a maneuver in pregnancy, however, could be detrimental. Clearly, more studies are needed to validate IAP measurement in this unique population.

The potential role of IAH in preeclampsia-eclampsia
---------------------------------------------------

Preeclampsia, part of a spectrum of hypertensive disorders of pregnancy, is defined as the development of arterial hypertension and proteinuria after 20 weeks gestation \[[@B40]\] and is associated with significant maternal morbidity and death \[[@B4],[@B40]\]. Preeclampsia-eclampsia, clinically, can present with one or more manifestations of either renal compromise, neurological sequelae including visual disturbances, headache, stroke, and eventually convulsions (eclampsia), to thrombocytopenia, fetal growth restriction, and liver and other hematologic abnormalities \[[@B41]\]. HELLP is considered a severe variant of preeclampsia and manifests as a syndrome of hemolysis, elevated liver enzymes, and low platelet count \[[@B41]\]. While some of these clinical manifestations, particularly eclampsia, have been well described as early as the mid-1600\'s \[[@B42]\], modern understanding of the etiology remains incomplete. The most commonly held hypothesis is that abnormal placentation occurs during the myometrial trophoblastic invasion in the second trimester \[[@B40]\], leading to placental ischemia and the release of angiogenic toxins, causing widespread endothelial dysfunction \[[@B41]\] and generalized inflammation. However, this immune maladaptation hypothesis has been recently questioned \[[@B43]\] as a result of recent epidemiologic studies. While its incidence worldwide is significant (3% to 5% of all pregnancies) \[[@B40]\], preeclampsia is a heterogeneous condition for which its commoner presentation in younger women in developing countries may be etiologically distinct than that of the somewhat older preeclamptic presentation in developed nations, with clinically \[[@B30]\] milder disease occurring later in gestation \[[@B43]\].

Two dramatic case reports described overt ACS as a complication of preeclampsia-eclampsia/HELLP syndromes requiring urgent life-saving interventions \[[@B12],[@B13]\]. The diagnosis of peripartum ACS in these cases was challenging not only due to the lack of well-established normative pregnant values of IAP, but also because of the overlap of signs and symptoms between ACS and severe preeclampsia such as oliguria and nonspecific abdominal pain \[[@B12]\]. Furthermore, we contend that ACS was unrecognized in these cases because the routine measurement of IAP generally has not been accepted in many ICUs. Akin to many other conditions in critical illness, clinicians too frequently do not consider the possible impact of IAH in the clinical picture, especially when the patient has not been injured or subjected to surgery \[[@B44],[@B45]\].

Even as early as the 1900s, investigators had suggested uncompensated elevated IAP as a possible etiologic factor in the development of preeclampsia \[[@B10],[@B46]\]. While elevated IAP may not be the only, sole, or critical inciting factor, its potential role in the development or progression of such syndromes certainly is plausible. Mauriceau noted the preponderance of \'toxemia\' of pregnancy in primiparas in 1694 \[[@B42]\]. Paramore, also noting this prevalence, hypothesized that nulliparous and muscular women were prone to spastic abdominal wall tone resulting in elevated IAPs, compromising perfusion pressure to the abdominopelvic viscera \[[@B10],[@B46]\]. Mulier was able to indeed confirm a linear relationship between abdominal pressure and volume to calculate the abdominal wall elastance (*E*) \[[@B47]\] and even found that *E*decreased significantly with increased age and gravidity \[[@B48]\]. Sugerman recently hypothesized that IAH played a central role in initiating the multi-system cascade of diminished perfusion and inflammation associated with the various clinical manifestations of preeclampsia \[[@B49]\]. He speculated obstructed venous return from IAH, essentially limiting abdominal perfusion pressure due to increased back pressure, resulted in decreased end-organ perfusion including both kidneys and the placenta. Thus, the activation of the renin-angiotensin system, with elevation of aldosterone levels, systemic hypertension, and placental ischemia/necrosis with an impact on fetal growth, was triggered \[[@B49]\].

That ACS occurs in this patient population is not really the question. Given the evidence in the literature to date (Table [1](#T1){ref-type="table"}), it is likely that term pregnancy is associated with elevated IAP to which the patient has adapted. It is also likely that the IAP is elevated in the immediate postpartum phase as well \[[@B32],[@B50]\], similar to the postoperative surgical populations \[[@B51]\]. What remains to be seen is whether preeclamptic patients truly have IAH, at what pressure does this occur, and whether IAH has a significant role the in the progression of the development of severe preeclampsia or HELLP.

IAH and the fetus
-----------------

Despite the limited understanding of IAH in maternal care, even less is known regarding its effects on the fetus. Whether there are subclinical effects of even modest elevations of maternal IAP on the fetus is completely unknown. Several animal studies have confirmed that the mammalian fetus *in utero*is subject to transmitted IAP \[[@B52],[@B53]\]. IAH was found to decrease uterine blood flow and induce a resultant compensatory fetal hypertension \[[@B54]\] such as during laparoscopy even with inert gasses rather than CO~2~. In a gravid rabbit model, Karnak et al. examined the relationship between maternal IAP and intra-amniotic pressure (IAMNP) through catheters inserted into both the intraperitoneal and intra-amniotic cavities at 20 days of gestation. Intraperitoneal air was insufflated to an IAP of 20 cmH~2~O. They found that IAMNP was linearly related to IAP as defined by IAMNP = IAP × 0.8 + 2.0. Further, they found that the elevation of IAMNP to 15.6 cmH~2~O via the elevation of the IAP (to 17 cmH~2~O) altered the contractile properties of the fetal bladder \[[@B53]\].

While we are aware of no modern human data correlating maternal IAH with any known effects on the fetus, concerns regarding the fetal-placental unit are neither entirely novel nor implausible. Tanyel \[[@B55]\] hypothesized that elevated IAMNP is translated to elevated fetal IAP, both of which were vulnerable to elevations in maternal IAP \[[@B55]\]. Through this mechanism, elevated fetal IAP could result in increased urethral resistance, the chronicity of which could lead to abnormal development of the bladder detrusor muscles, resultant dysfunctional voiding in children, and possible urinary tract anomalies \[[@B55]\]. Although the etiology of such syndromes is likely multifactorial, exploration of the impact of pathological maternal IAH on the feto-placental unit could be another area of fruitful potential investigation.

Ovarian hyperstimulation syndrome
---------------------------------

Ovarian hyperstimulation syndrome (OHSS) is a not an uncommon complication of ovulation induction for assisted reproduction \[[@B56],[@B57]\]. The mechanism is not entirely understood but is thought to be mediated by vasoactive cytokines in response to exogenous administration of human chorionic gonadotropin \[[@B58]\]. Significant third spacing as a result of capillary vascularity due to ovarian neoangiogenesis can occur \[[@B56]\], and in its most severe form, massive and rapid accumulation of abdominal ascites results in an overt ACS \[[@B58]\]. Management for this condition ranges from conservative observation to intensive care admission with IAP monitoring and paracentesis to relieve ACS \[[@B57],[@B58]\]. As assisted reproduction increases in prevalence, it becomes imperative to recognize this relatively common complication and to consider the potential role of IAH in its pathophysiology.

Like OHSS, rapid growth in abdominal girth, dyspnea, abdominal pain, and other overt symptoms of ACS in other gynecological conditions must also be considered in the differential. Patients undergoing ovulation induction are also at increased risk of ovarian torsion and ectopic pregnancy \[[@B57]\]. Meigs\' syndrome, solid ovarian tumors associated with hydrothorax and ascites, has been described similarly to OHSS in presenting with symptoms of ACS \[[@B59]\]. However, while OHSS is often self-limited with conservative management as a viable option, definitive therapy for Meigs\' syndrome would be surgical removal of the tumor itself \[[@B59]\].

Conclusions
===========

It is currently a recommended standard for any newly admitted critically ill patient with any two IAH risk factors to have baseline IAP measured \[[@B38]\]. The critically ill pregnant patient typically has positive generic risk factors for IAH such as \'acute respiratory failure with elevated intrathoracic pressures\' and \'increased abdominal contents\' in later pregnancy, in addition to those specific to their inciting illness. If IAP is not measured, IAH will often be missed. Further, the lack of knowledge of the behavior of IAH in pregnancy risks the potential disaster of missed or delayed diagnosis of ACS resulting in morbidity and mortality in a relatively young and otherwise healthy cohort. Despite these high stakes, there is almost no data to guide evidence-based decisions. At the bedside, measuring the IAP and considering IAH in all critical maternal conditions is essential, especially in preeclampsia-eclampsia where some have hypothesized that IAH may have an additional role. Research is urgently needed to define the normal range of IAP in all phases of pregnancy. This may be better facilitated with the validation of less invasive IAP measurement alternatives such as the measurement of wall tension \[[@B60]\] or via gastric tonometry \[[@B61]\]. The IAP in pregnancy must take into account the precautions for aorto-caval compression. The potential impact of maternal IAH on fetal development is essentially unknown. Finally, IAH leading to ACS is a real and potential complication in early induced pregnancy. Measurement of the IAP should be performed in the management of OHSS.
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